Welcome to This Week in Waste, a series by Citizens Against Government Waste (CAGW) that highlights how taxpayer dollars are being wasted in the federal, state, and local levels of government and efforts to fight back against this spendthrift behavior. Senate Health, Education, Labor, and Pensions (HELP) Committee Hearing is Next Step for 340B Reform The […]
President Trump Can Cut Wasteful Spending to Reduce Drug Prices and Healthcare Costs
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
Combating Improper Payments in Federal Spending
Improper payments have long been an avoidable drain on the federal budget and are often prominently featured as an example of wasteful spending. It is therefore not surprising that in the August 12, 2025, Government Accountability Office (GAO) updated report on open recommendations to improve government operations, reducing fraud and improper payments was first on […]
The IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Not-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Medicare Advantage Should Not Be Disadvantaged
Taxpayers and beneficiaries should be concerned with the Biden administration’s proposed cuts to Medicare Advantage.
Biden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
Bad Policies Are Being Proposed by HHS Secretary Nominee Xavier Becerra
The first clue that Joe Biden, the presumptive 46th President of the United States, was choosing someone he did not know well as his nominee for secretary of HHS was when he mispronounced his name and incorrectly named the agency he would direct.
Bidencare: A Straight Line to Government-Run Healthcare
Former Vice President Biden argued in his recent debate with President Trump that he does not want “Medicare for All” but wants “Bidencare” where a public option would be added to the Patient Protection and Affordable Care Act (ACA). But that’s a straight line to government-run healthcare.










